Healthcare provider profile · identity verified

Jonathan A Sneller, D.O.

Family Practice · EPHRATA, PA · NPI 1417987991

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	444	125
Levothyroxine Sodium	Levothyroxine Sodium	425	97
Rosuvastatin Calcium	Rosuvastatin Calcium	390	106
Lisinopril	Lisinopril	354	96
Atorvastatin Calcium	Atorvastatin Calcium	323	88
Losartan Potassium	Losartan Potassium	289	78
Metoprolol Succinate	Metoprolol Succinate	272	70
Omeprazole	Omeprazole	260	67
Sertraline Hcl	Sertraline Hcl	190	42
Potassium Chloride	Potassium Chloride	176	38
Eliquis	Apixaban	163	31
Metoprolol Tartrate	Metoprolol Tartrate	153	31
Tamsulosin Hcl	Tamsulosin Hcl	152	38
Metformin Hcl	Metformin Hcl	146	37
Lorazepam	Lorazepam	145	37
Montelukast Sodium	Montelukast Sodium	141	26
Simvastatin	Simvastatin	139	32
Gabapentin	Gabapentin	135	36
Fluticasone Propionate	Fluticasone Propionate	129	36
Bupropion Xl	Bupropion Hcl	119	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	119	21
Glimepiride	Glimepiride	118	32
Jardiance	Empagliflozin	118	25
Furosemide	Furosemide	116	36
Hydrochlorothiazide	Hydrochlorothiazide	116	31
Prednisone	Prednisone	114	78
Escitalopram Oxalate	Escitalopram Oxalate	112	25
Trazodone Hcl	Trazodone Hcl	105	26
Pantoprazole Sodium	Pantoprazole Sodium	104	31
Pregabalin	Pregabalin	104	19
Famotidine	Famotidine	102	25
Duloxetine Hcl	Duloxetine Hcl	101	20
Fluoxetine Hcl	Fluoxetine Hcl	101	29
Pioglitazone Hcl	Pioglitazone Hcl	99	22
Xarelto	Rivaroxaban	93	18
Clonazepam	Clonazepam	90	16
Zolpidem Tartrate	Zolpidem Tartrate	87	21
Oxycodone Hcl	Oxycodone Hcl	86	15
Carvedilol	Carvedilol	85	17
Venlafaxine Hcl Er	Venlafaxine Hcl	84	17
Pravastatin Sodium	Pravastatin Sodium	79	22
Synthroid	Levothyroxine Sodium	79	17
Clopidogrel	Clopidogrel Bisulfate	75	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	17
Metformin Hcl Er	Metformin Hcl	73	23
Ropinirole Hcl	Ropinirole Hcl	73	14
Albuterol Sulfate Hfa	Albuterol Sulfate	70	29
Quetiapine Fumarate	Quetiapine Fumarate	69	15
Citalopram Hbr	Citalopram Hydrobromide	65	18
Topiramate	Topiramate	63	12
Alendronate Sodium	Alendronate Sodium	61	17
Allopurinol	Allopurinol	61	16
Tramadol Hcl	Tramadol Hcl	58	16
Fentanyl	Fentanyl	55	suppressed
Buspirone Hcl	Buspirone Hcl	54	14
Ozempic	Semaglutide	54	12
Chlorthalidone	Chlorthalidone	52	16
Sumatriptan Succinate	Sumatriptan Succinate	49	suppressed
Valsartan	Valsartan	49	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Mirtazapine	Mirtazapine	46	18
Alprazolam	Alprazolam	44	suppressed
Azithromycin	Azithromycin	43	32
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	38
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	14
Finasteride	Finasteride	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	39	30
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Cephalexin	Cephalexin	36	27
Enalapril Maleate	Enalapril Maleate	35	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Baclofen	Baclofen	33	11
Dicyclomine Hcl	Dicyclomine Hcl	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Meloxicam	Meloxicam	33	11
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Glipizide	Glipizide	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	14
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Spironolactone	Spironolactone	28	11
Diclofenac Sodium	Diclofenac Sodium	27	13
Mounjaro	Tirzepatide	27	12
Nifedipine Er	Nifedipine	27	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Atenolol	Atenolol	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Testosterone Cypionate	Testosterone Cypionate	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	11
Benazepril Hcl	Benazepril Hcl	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Naproxen	Naproxen	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Amoxicillin	Amoxicillin	21	16
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	15
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Jantoven	Warfarin Sodium	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Telmisartan	Telmisartan	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Diazepam	Diazepam	16	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Icosapent Ethyl	Icosapent Ethyl	16	suppressed
Lamotrigine Er	Lamotrigine	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	15	13
Latanoprost	Latanoprost	15	suppressed
Np Thyroid	Thyroid,pork	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Nucynta	Tapentadol Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Digoxin	Digoxin	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Methimazole	Methimazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	12
Pindolol	Pindolol	12	suppressed
Savella	Milnacipran Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	11	suppressed
Jentadueto Xr	Linagliptin/Metformin Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Semglee (Yfgn)	Insulin Glargine-Yfgn	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error